Myosin
From Proteopedia
(Difference between revisions)
Line 39: | Line 39: | ||
==Disease== | ==Disease== | ||
Mutations in MIIA cause early onset myopathy<ref>PMID:20418530</ref>. Mutations in MVIIA cause Usher syndrome<ref>PMID:7870171</ref>. | Mutations in MIIA cause early onset myopathy<ref>PMID:20418530</ref>. Mutations in MVIIA cause Usher syndrome<ref>PMID:7870171</ref>. | ||
+ | |||
+ | == 3D Structures of Myosin == | ||
+ | [[Myosin 3D Structures]] | ||
+ | |||
</StructureSection> | </StructureSection> | ||
Line 48: | Line 52: | ||
* Myosin I | * Myosin I | ||
+ | **[[4byf]] – hMIC + calmodulin – human<br /> | ||
+ | **[[2xmf]] – mMI SH3 domain - mouse<br /> | ||
+ | **[[5h53]] - rMI LC+HC + rActin – rabbit - Cryo EM<br /> | ||
**[[1lkx]], [[5ejy]] – DdMI HC - ''Dictyostelium discoideum''<br /> | **[[1lkx]], [[5ejy]] – DdMI HC - ''Dictyostelium discoideum''<br /> | ||
**[[5ejs]] – DdMI HC (mutant)<br /> | **[[5ejs]] – DdMI HC (mutant)<br /> | ||
- | **[[4a7f]] - DdMI HC + rActin + rTropomyosin | + | **[[4a7f]] - DdMI HC + rActin + rTropomyosin – Cryo EM<br /> |
**[[4a7h]], [[4a7l]] - DdMI HC (mutant) + rActin + rTropomyosin – Cryo EM<br /> | **[[4a7h]], [[4a7l]] - DdMI HC (mutant) + rActin + rTropomyosin – Cryo EM<br /> | ||
**[[5ibw]] – DdMIC HC + Ca-binding protein <br /> | **[[5ibw]] – DdMIC HC + Ca-binding protein <br /> | ||
**[[2drk]], [[2drm]] – MI HC + 10-mer peptide – ''Acanthamoeba castellanii''<br /> | **[[2drk]], [[2drm]] – MI HC + 10-mer peptide – ''Acanthamoeba castellanii''<br /> | ||
- | **[[ | + | **[[6i7e]], [[6i7d]] – MI – ''Plasmodium falciparum''<br /> |
- | + | ||
- | + | ||
*Unconventional myosin I | *Unconventional myosin I | ||
Line 64: | Line 69: | ||
**[[4l79]] – raMIB + calmodulin <br /> | **[[4l79]] – raMIB + calmodulin <br /> | ||
**[[6c1d]] – raMIB + calmodulin + actin + phalloidin – Cryo EM<br /> | **[[6c1d]] – raMIB + calmodulin + actin + phalloidin – Cryo EM<br /> | ||
- | **[[5xgg]], [[5xg9]] – MIB C-terminal SH3 – ''Entamoeba histolytica''<br /> | ||
**[[4r8g]] – mMIC C-terminal + calmodulin<br /> | **[[4r8g]] – mMIC C-terminal + calmodulin<br /> | ||
+ | **[[5xgg]], [[5xg9]] – EhMIB C-terminal SH3 – ''Entamoeba histolytica''<br /> | ||
+ | **[[6a9c]] – EhMIB C-terminal SH3 + FP10 peptide<br /> | ||
* Myosin II | * Myosin II | ||
Line 101: | Line 107: | ||
**[[2aka]] - DdMII HC+dynamin-1<br /> | **[[2aka]] - DdMII HC+dynamin-1<br /> | ||
**[[2xel]], [[4ae3]] – DdMII HC + inhibitor<br /> | **[[2xel]], [[4ae3]] – DdMII HC + inhibitor<br /> | ||
- | **[[1n2d]] – | + | **[[6ixo]] – yMII GTD - yeast<br /> |
- | **[[1m45]] - | + | **[[1n2d]] – yMII LC+IQ2 IQ3 motifs from Myo2p<br /> |
- | **[[1m46]] - | + | **[[1m45]] - yMII LC+IQ2 motif from Myo2p<br /> |
+ | **[[1m46]] - yMII LC+IQ4 motif from Myo2p<br /> | ||
+ | **[[6ixr]], [[6ixq]], [[6ixp]] – yMII GTD (mutant) + peptide<br /> | ||
**[[2bl0]] – MII RLC +RHC – ''Physarum polycephalum''<br /> | **[[2bl0]] – MII RLC +RHC – ''Physarum polycephalum''<br /> | ||
**[[5w1a]] - MII HC MD + LC – ''Drosophila melanogaster''<br /> | **[[5w1a]] - MII HC MD + LC – ''Drosophila melanogaster''<br /> | ||
Line 116: | Line 124: | ||
*Myosin IV | *Myosin IV | ||
- | **[[3mmi]] – yMIV | + | **[[3mmi]] – yMIV GTD <br /> |
- | **[[4ll6]] - yMIV | + | **[[4ll6]] - yMIV GTD (mutant)<br /> |
- | **[[4ll8]] - yMIV | + | **[[4ll8]] - yMIV GTD (mutant) + SHE3P<br /> |
+ | **[[6qdj]] – MIV – ''Caenorhabditis elegans'' <br /> | ||
+ | |||
+ | *Myosin V | ||
+ | |||
+ | **[[6eyw]] - yMV CBD<br /> | ||
* Myosin V (Unconventional myosin) | * Myosin V (Unconventional myosin) | ||
Line 133: | Line 146: | ||
**[[4zlk]] - mMVA + calmodulin<br /> | **[[4zlk]] - mMVA + calmodulin<br /> | ||
**[[2ix7]] – mMVA IQ motif +apo-calmodulin <br /> | **[[2ix7]] – mMVA IQ motif +apo-calmodulin <br /> | ||
- | **[[3wb8]] – mMVA | + | **[[3wb8]] – mMVA GTD<br /> |
- | **[[4j5l]], [[4j5m]] – hMVA | + | **[[4j5l]], [[4j5m]] – hMVA GTD<br /> |
- | **[[4kp3]] – mMVA | + | **[[4kp3]] – mMVA GTD + RILP-like protein + melanophilin<br /> |
- | **[[4lli]] – hMVA | + | **[[4lli]] – hMVA CBD<br /> |
- | **[[4lx1]] – hMVA | + | **[[4lx1]] – hMVA GTD<br /> |
- | **[[4lx2]] – hMVA | + | **[[4lx2]] – hMVA GTD + melanphilin<br /> |
- | **[[5jcz]] – hMVA | + | **[[5jcz]] – hMVA GTD + RAB-11<br /> |
- | **[[5jcy]] – hMVA | + | **[[5jcy]] – hMVA GTD + SPIR-2<br /> |
- | **[[4lnz]] – hMVB | + | **[[4lnz]] – hMVB GTD<br /> |
- | **[[4lwz]], [[4lx0]] – hMVB | + | **[[4lwz]], [[4lx0]] – hMVB GTD + RAS-related protein<br /> |
**[[5hmp]], [[4zg4]] – hMVC <br /> | **[[5hmp]], [[4zg4]] – hMVC <br /> | ||
- | **[[4l8t]] – hMVC | + | **[[4l8t]] – hMVC CBD<br /> |
* Myosin VI | * Myosin VI | ||
Line 163: | Line 176: | ||
**[[6bnw]], [[6bnq]], [[6bnp]] – pMVI + actin – Cryo EM<br /> | **[[6bnw]], [[6bnq]], [[6bnp]] – pMVI + actin – Cryo EM<br /> | ||
**[[6bnv]] – pMVI + actin + calmodulin – Cryo EM<br /> | **[[6bnv]] – pMVI + actin + calmodulin – Cryo EM<br /> | ||
+ | **[[6bnv]] – MVI residus 1-69 – ''Meriones unguiculatus''<br /> | ||
*Unconventional myosin VI | *Unconventional myosin VI | ||
+ | **[[6j56]] – hMVI CBD + TOM1 peptide <br /> | ||
**[[5v6h]] – mMVI + GIPC2 <br /> | **[[5v6h]] – mMVI + GIPC2 <br /> | ||
**[[5v6e]] – mMVI + GIPC1 <br /> | **[[5v6e]] – mMVI + GIPC1 <br /> | ||
Line 196: | Line 211: | ||
**[[5c5s]] – hMIXB RHOGAP domain <br /> | **[[5c5s]] – hMIXB RHOGAP domain <br /> | ||
- | **[[5hpy]] – hMIXB | + | **[[5hpy]] – hMIXB MD + RHOA <br /> |
*Myosin X | *Myosin X | ||
Line 207: | Line 222: | ||
*Unconventional myosin X | *Unconventional myosin X | ||
- | **[[5i0h]] – hMX | + | **[[5i0h]] – hMX MD <br /> |
- | **[[5kg8]] – hMX | + | **[[5kg8]] – hMX MD + actin <br /> |
- | **[[5i0i]] – hMX | + | **[[5i0i]] – hMX MD + calmodulin <br /> |
**[[5hmo]] – MX SAH + coiled-coil domain - bovine <br /> | **[[5hmo]] – MX SAH + coiled-coil domain - bovine <br /> | ||
*Myosin XI | *Myosin XI | ||
- | **[[5t45]] – cMXI | + | **[[5t45]] – cMXI MD <br /> |
- | **[[5m05]] – cMXI | + | **[[5m05]] – cMXI MD + inhibitor <br /> |
- | **[[3j04]] – cMXI HC + RLC – Cryo EM | + | **[[3j04]] – cMXI HC + RLC – Cryo EM<br /> |
+ | **[[6bih]] – cMXI HC + actin – Cryo EM<br /> | ||
+ | |||
+ | *Unconventional myosin XIV | ||
+ | |||
+ | **[[6due]] – MXIV – ''Toxoplasma gondii'' <br /> | ||
*Flight muscle myosin | *Flight muscle myosin |
Revision as of 10:07, 5 November 2019
|
3D Structures of Myosin
Updated on 05-November-2019
References
- ↑ Spudich JA, Finer J, Simmons B, Ruppel K, Patterson B, Uyeda T. Myosin structure and function. Cold Spring Harb Symp Quant Biol. 1995;60:783-91. PMID:8824453
- ↑ Kalhammer G, Bahler M. Unconventional myosins. Essays Biochem. 2000;35:33-42. PMID:12471888
- ↑ Matsumura F. Regulation of myosin II during cytokinesis in higher eukaryotes. Trends Cell Biol. 2005 Jul;15(7):371-7. PMID:15935670 doi:http://dx.doi.org/10.1016/j.tcb.2005.05.004
- ↑ Mehta AD, Rock RS, Rief M, Spudich JA, Mooseker MS, Cheney RE. Myosin-V is a processive actin-based motor. Nature. 1999 Aug 5;400(6744):590-3. PMID:10448864 doi:http://dx.doi.org/10.1038/23072
- ↑ Buss F, Spudich G, Kendrick-Jones J. Myosin VI: cellular functions and motor properties. Annu Rev Cell Dev Biol. 2004;20:649-76. PMID:15473855 doi:http://dx.doi.org/10.1146/annurev.cellbio.20.012103.094243
- ↑ Hasson T, Skowron JF, Gilbert DJ, Avraham KB, Perry WL, Bement WM, Anderson BL, Sherr EH, Chen ZY, Greene LA, Ward DC, Corey DP, Mooseker MS, Copeland NG, Jenkins NA. Mapping of unconventional myosins in mouse and human. Genomics. 1996 Sep 15;36(3):431-9. PMID:8884266 doi:http://dx.doi.org/10.1006/geno.1996.0488
- ↑ Cox D, Berg JS, Cammer M, Chinegwundoh JO, Dale BM, Cheney RE, Greenberg S. Myosin X is a downstream effector of PI(3)K during phagocytosis. Nat Cell Biol. 2002 Jul;4(7):469-77. PMID:12055636 doi:http://dx.doi.org/10.1038/ncb805
- ↑ Tamura K, Iwabuchi K, Fukao Y, Kondo M, Okamoto K, Ueda H, Nishimura M, Hara-Nishimura I. Myosin XI-i links the nuclear membrane to the cytoskeleton to control nuclear movement and shape in Arabidopsis. Curr Biol. 2013 Sep 23;23(18):1776-81. doi: 10.1016/j.cub.2013.07.035. Epub 2013 , Aug 22. PMID:23973298 doi:http://dx.doi.org/10.1016/j.cub.2013.07.035
- ↑ 9.0 9.1 9.2 9.3 9.4 9.5 Rayment I, Rypniewski WR, Schmidt-Base K, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science. 1993 Jul 2;261(5117):50-8. PMID:8316857
- ↑ 10.0 10.1 10.2 Nelson, D. and Cox, M.(2005). Lehninger Principles of Biochemistry. 4th ed. p.1119.
- ↑ Tajsharghi H, Hilton-Jones D, Raheem O, Saukkonen AM, Oldfors A, Udd B. Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations. Brain. 2010 May;133(Pt 5):1451-9. doi: 10.1093/brain/awq083. PMID:20418530 doi:http://dx.doi.org/10.1093/brain/awq083
- ↑ Weil D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, Mburu P, Varela A, Levilliers J, Weston MD, et al.. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature. 1995 Mar 2;374(6517):60-1. PMID:7870171 doi:http://dx.doi.org/10.1038/374060a0
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, David Canner, Laurel Koopmans, Jaime Prilusky